How Long Does Sundowning Last in Dementia?

Sundowning episodes typically begin in the late afternoon and last into the night, often spanning several hours from around dusk until the person settles into sleep. As a phase within dementia’s progression, sundowning can persist for months or even years, most commonly appearing during the middle and later stages of the disease. There’s no single, predictable timeline, which is part of what makes it so difficult for caregivers to plan around.

How Long a Daily Episode Lasts

A sundowning episode usually starts between 4 and 6 p.m. as daylight fades. It can last anywhere from a couple of hours to the entire evening and into the night. Some people experience a relatively brief window of agitation or confusion that eases once they’re in a calm, well-lit environment. Others remain restless, disoriented, or anxious for four to six hours or more, sometimes not settling until well past midnight.

The length of each episode varies from day to day, even in the same person. Days with more physical activity, emotional stress, or disrupted sleep the night before tend to produce longer, more intense episodes. Infections, dehydration, pain, and medication side effects can also extend episodes significantly. On quieter, well-structured days, the same person may barely show symptoms at all.

How Long Sundowning Persists Across the Disease

Sundowning can appear at any stage of dementia, but it clusters in the middle to later stages. Roughly 20% of people diagnosed with Alzheimer’s disease experience it, though reported prevalence ranges widely (from about 2.5% to 66%) depending on how studies define and measure it. Once it begins, sundowning tends to recur for months to years as the disease progresses.

There’s no clean start and stop point. It often emerges gradually: an occasional restless evening becomes a nightly pattern. In some people, sundowning eventually diminishes in the very late stages of dementia, when overall mobility and wakefulness decline. But this isn’t universal, and the transition isn’t a relief so much as a shift in the type of care needed.

Why It Happens at Dusk

The brain has an internal clock located in a small region of the hypothalamus that relies on light signals from the eyes and melatonin from the pineal gland to keep the sleep-wake cycle on track. Melatonin acts as a darkness signal, telling the body when it’s nighttime. In Alzheimer’s and other dementias, the neurons in this clock region degenerate, and melatonin production becomes irregular. The result is that the brain loses its ability to smoothly transition between day mode and night mode.

As natural light dims in the late afternoon, a healthy brain ramps up melatonin production in an orderly way. A damaged brain responds erratically, producing confusion, anxiety, and agitation right at the boundary between day and night. Low indoor lighting and the long shadows of late afternoon can make this worse by reducing visual cues that help an already-disoriented person make sense of their surroundings.

Common Triggers That Extend Episodes

Several factors can make episodes start earlier, last longer, or feel more severe:

  • Sleep deprivation. Poor sleep the night before is one of the strongest predictors of a bad episode the following evening.
  • Fatigue and overstimulation. A busy day with visitors, appointments, or travel can leave the person mentally exhausted by late afternoon.
  • Low lighting. Dim rooms and shadows create visual confusion, making unfamiliar surroundings feel threatening.
  • Pain or physical illness. A urinary tract infection, constipation, or untreated pain can dramatically worsen behavioral symptoms, and the person may not be able to communicate what’s wrong.
  • Dehydration. Inadequate fluid intake throughout the day contributes to confusion.
  • Medication side effects. Some drugs cause drowsiness or disorientation that compounds the natural dusk-time confusion.

Addressing these triggers won’t eliminate sundowning, but it can meaningfully shorten episodes and reduce their intensity. A person whose evening agitation regularly lasts four hours might settle within one or two hours when underlying pain is treated or sleep quality improves.

Light Therapy and Daily Routines

Bright light therapy is one of the most studied non-drug approaches. The standard protocol uses a light box delivering 10,000 lux of full-spectrum white light for 30 minutes in the morning. If that intensity isn’t available, lower levels work with longer exposure: 60 minutes at 5,000 lux, or 90 minutes at 2,500 lux. The goal is to reset the internal clock by giving the brain a strong daytime light signal, which helps it distinguish day from night more reliably. If morning sessions alone don’t help within one to two weeks, adding an afternoon or early evening session is often the next step.

Daily routine adjustments also make a real difference. Keeping the person active and engaged earlier in the day, then shifting to calm, low-stimulation activities by mid-afternoon, helps prevent the fatigue buildup that feeds sundowning. Turning on bright indoor lights well before dusk, so the transition from daylight to evening isn’t abrupt, reduces the visual disorientation that can trigger an episode. Consistent mealtimes and a predictable bedtime routine reinforce the body’s sense of time passing in an orderly way.

What About Melatonin?

Given that disrupted melatonin signaling is part of the problem, supplemental melatonin seems like an obvious fix. The reality is more complicated. Studies in dementia patients have used doses ranging from less than 1 mg to 10 mg taken before bed, with mixed results. Some trials combining morning light therapy with 5 mg of evening melatonin showed improvements in circadian regulation, but a 2020 review of the evidence found that melatonin alone may have little effect on sleep outcomes in people with dementia.

The American Academy of Sleep Medicine has recommended against melatonin and similar sleep-promoting medications for elderly dementia patients due to increased fall risk. This doesn’t mean melatonin is never appropriate, but it highlights that what works for healthy adults with jet lag doesn’t automatically translate to a brain with significant neurodegeneration. Any supplement use should be discussed with the person’s care team, particularly because melatonin can interact with other medications common in this population.

What Caregivers Can Realistically Expect

Sundowning is not a problem that gets solved once. It waxes and wanes over months and years. Some weeks are manageable, others are exhausting. The strategies that work, like consistent routines, bright lighting, trigger management, and sometimes light therapy, don’t cure sundowning. They compress it. A six-hour nightly ordeal might become a one-hour period of mild restlessness, which changes a caregiver’s life considerably even if it doesn’t eliminate the behavior.

Planning your own rest around the pattern is essential. If episodes reliably start around 5 p.m. and the person is usually settled by 9 or 10 p.m., structuring your evening around that window (having dinner prepared early, keeping the environment calm, having a second caregiver or family member present during peak hours) makes the episode feel less like a crisis and more like a predictable part of the day. Tracking episodes in a simple log, noting start time, end time, and possible triggers, often reveals patterns that aren’t obvious in the moment but become clear over a week or two of data.